(0.28%) 5 114.24 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-1.59%) $82.52
(5.10%) $2.02
(0.29%) $2 354.00
(0.19%) $27.59
(4.06%) $959.50
(-0.19%) $0.933
(-0.36%) $10.99
(-0.52%) $0.796
(1.70%) $93.44
-2.71% INR 527.65
Live Chart Being Loaded With Signals
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India...
Stats | |
---|---|
Dagens volum | 169 341 |
Gjennomsnittsvolum | 556 297 |
Markedsverdi | 18.99B |
EPS | INR0 ( 2024-02-14 ) |
Neste inntjeningsdato | ( INR0 ) 2024-05-09 |
Last Dividend | INR3.00 ( 2021-08-18 ) |
Next Dividend | INR0 ( N/A ) |
P/E | -6.16 |
ATR14 | INR1.113 (0.21%) |
Volum Korrelasjon
Solara Active Pharma Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Solara Active Pharma Korrelasjon - Valuta/Råvare
Solara Active Pharma Økonomi
Annual | 2022 |
Omsetning: | INR14.44B |
Bruttogevinst: | INR6.55B (45.37 %) |
EPS: | INR-6.16 |
FY | 2022 |
Omsetning: | INR14.44B |
Bruttogevinst: | INR6.55B (45.37 %) |
EPS: | INR-6.16 |
FY | 2022 |
Omsetning: | INR12.31B |
Bruttogevinst: | INR5.33B (43.29 %) |
EPS: | INR-16.22 |
FY | 2021 |
Omsetning: | INR16.17B |
Bruttogevinst: | INR8.47B (52.40 %) |
EPS: | INR69.00 |
Financial Reports:
No articles found.
Solara Active Pharma Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
First Dividend | INR5.00 | 2019-08-06 |
Last Dividend | INR3.00 | 2021-08-18 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 4 | -- |
Total Paid Out | INR14.00 | -- |
Avg. Dividend % Per Year | 0.13% | -- |
Score | 0.73 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 1.727 | |
Div. Directional Score | 0.448 | -- |
Year | Amount | Yield |
---|---|---|
2019 | INR5.00 | 1.62% |
2020 | INR6.00 | 1.41% |
2021 | INR3.00 | 0.25% |
2022 | INR0 | 0.00% |
2023 | INR0 | 0.00% |
2024 | INR0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PARADEEP.NS | No Dividend Player | 2023-09-18 | Insufficient data to determine frequency | 2 | 0.28% | |
IVC.NS | Dividend Knight | 2023-08-17 | Annually | 23 | 5.55% | |
DALBHARAT.NS | Dividend Junior | 2023-06-23 | Annually | 7 | 0.30% | |
SHRIPISTON.NS | Dividend Junior | 2023-06-27 | Semi-Annually | 9 | 0.89% | |
MATRIMONY.NS | Dividend Junior | 2023-08-03 | Annually | 7 | 0.41% | |
GRWRHITECH.NS | Dividend Junior | 2023-09-20 | Semi-Annually | 3 | 0.88% | |
BANDHANBNK.NS | Dividend Junior | 2023-08-11 | Sporadic | 7 | 0.20% | |
PPAP.NS | Ex Dividend Junior | 2023-09-08 | Annually | 17 | 0.34% | |
JWL.NS | Dividend Junior | 2023-09-12 | Insufficient data to determine frequency | 2 | 0.17% | |
DSSL.NS | Dividend Junior | 2023-08-23 | Annually | 6 | 0.34% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.219 | 1.500 | -4.38 | -6.57 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | -0.276 | 1.500 | -4.18 | -6.27 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | -1.607 | 1.000 | -1.706 | -1.706 | [3 - 30] |
operatingCashFlowPerShareTTM | 43.40 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 43.40 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.342 | 1.000 | 7.64 | 7.64 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.110 | 1.000 | -4.20 | -4.20 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | -0.832 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -6.29 | 1.000 | -0.737 | 0 | [1 - 100] |
returnOnEquityTTM | -0.276 | 2.50 | -2.69 | -6.27 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 43.40 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 43.40 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.111 | 1.000 | 9.72 | 0 | [0.1 - 0.5] |
Total Score | 1.727 |
Solara Active Pharma
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India. The company offers APIs for anesthetics, anthelmintic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-viral, antibiotic, anticoagulant, anticonvulsant, antidepressant, antiemetic, antiepileptic, antifungal, antigout agent, antihistamine, antihyperlipoproteinemic, antimalarial, antimycotic, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antitussive, antiulcerative, anxiolytic, bile acid analogue, calcimimetic agent, cardiovascular agent, central nervous system agent, chronic alcoholism, chronic kidney disease, dopamine receptor antagonist, folate analog, hyperkalaemia, immunosuppressant, lipid regulating agent, loop diuretic, muscarinic agonist, neuromuscular, OAB treatment, phenylalanine reducer, recovery of stroke, tardive dyskinesia, treatment of glaucoma and hyperphosphatemia, tropical anti-infective, and type-II diabetes therapeutic categories. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and regulatory support. In addition, the company exports its products. It operates in the Asia Pacific, Europe, North America, South America, and internationally. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.